eComment. Septal reduction therapy for hypertrophic cardiomyopathy: the need of experienced centres

被引:0
|
作者
Garcia-Villarreal, Ovidio A. [1 ]
机构
[1] Hosp Cardiovasc Dis 34, IMSS, Dept Cardiac Surg, Monterrey, Mexico
关键词
D O I
10.1093/icvts/ivs468
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:9 / 10
页数:2
相关论文
共 50 条
  • [31] Septal reduction therapy using nonalcohol agent in hypertrophic obstructive cardiomyopathy: Single center experience
    Asil, Serkan
    Kaya, Baris
    Canpolat, Ugur
    Yorgun, Hikmet
    Sahiner, Levent
    Coteli, Cem
    Arat, Anil
    Aytemir, Kudret
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (03) : 557 - 565
  • [32] Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    Mazur, W
    Nagueh, SF
    Lakkis, NM
    Middleton, KJ
    Killip, D
    Roberts, R
    Spencer, WH
    CIRCULATION, 2001, 103 (11) : 1492 - 1496
  • [33] Balloon positioning difficulties during nonsurgical septal reduction therapy in a patient with hypertrophic obstructive cardiomyopathy
    Dudek, D
    Gil, R
    Dimitrow, PP
    Legutko, J
    Pieniazek, P
    Grodecki, J
    Przewlocki, T
    Zmudka, K
    Tracz, W
    Dubiel, JS
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2000, 49 (03) : 314 - 317
  • [34] Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
    Altibi, Ahmed M.
    Ghanem, Fares
    Zhao, Yuanzi
    Elman, Miriam
    Cigarroa, Joaquin
    Nazer, Babak
    Song, Howard K.
    Masri, Ahmad
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [35] Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients
    Lakkis, N
    Plana, JC
    Nagueh, S
    Killip, D
    Roberts, R
    Spencer, WH
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (05): : 583 - +
  • [36] Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
    Zheng, Xifeng
    Yang, Bin
    Hui, Haosheng
    Lu, Bing
    Feng, Yinhui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [37] The Risk of Ventricular Arrhythmias between Alcohol Septal Ablation and Septal Myectomy in Hypertrophic Cardiomyopathy: A Meta-Analysis on Septal Reduction Therapy
    Tang, Wei
    Liu, Menghui
    Li, Jie
    Chang, Rongxuan
    Su, Chen
    Zhang, Xiaoyu
    Wang, Lichun
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (12)
  • [38] Predictors of Repeated Septal Reduction After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy
    Hiruma, Takashi
    Kitamura, Mitsunobu
    Takamisawa, Itaru
    Izumi, Yuki
    Higuchi, Ryosuke
    Nanasato, Mamoru
    Shimokawa, Tomoki
    Takanashi, Shuichiro
    Isobe, Mitsuaki
    Takayama, Morimasa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (04)
  • [39] Interventional septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy- a relief also for the right ventricle?
    Sosdean, R.
    Mircea, M.
    Pascalau, L.
    Pescariu, S. A.
    Cristescu, R.
    Sturza, A.
    Luca, C. T.
    Mornos, C.
    Ionac, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 380 - 380
  • [40] Predictors of outcome after non-surgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
    Chang, SM
    Lakkis, NM
    Spencer, WH
    Nagueh, SF
    CIRCULATION, 2003, 108 (17) : 492 - 493